Peru vs South-East Asia (WHO region): Confirmed cases of MDR-TB started treatment for MDR-TB
Peru
100.0%
in 2012
South-East Asia (WHO region)
83.0%
in 2012
Peru rank
3rd
South-East Asia (WHO region) rank
5th
Confirmed cases of MDR-TB started treatment for MDR-TB over time
- Peru
- South-East Asia (WHO region)
How they compare
Peru currently reports 100.0% against 83.0% in South-East Asia (WHO region), a difference of 17.0%.
That makes Peru's figure about 1.2 times South-East Asia (WHO region)'s.
Across all 5 years both countries report, Peru has been ahead every year.
Peru ranks 3rd and South-East Asia (WHO region) ranks 5th of 54 countries.
Peru has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Peru | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 108.0% | 61.0% | 47.0% | Peru |
| 2010s | 90.0% | 83.0% | 7.0% | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher confirmed cases of mdr-tb started treatment for mdr-tb, Peru or South-East Asia (WHO region)?
- Peru, at 100.0% against 83.0% in South-East Asia (WHO region) as of 2012.
- What is the difference in confirmed cases of mdr-tb started treatment for mdr-tb between Peru and South-East Asia (WHO region)?
- 17.0%, with Peru ahead.
- How many years of comparable data are there for Peru and South-East Asia (WHO region)?
- 5 years are reported by both, from 2008 to 2012.
- How do Peru and South-East Asia (WHO region) rank globally for confirmed cases of mdr-tb started treatment for mdr-tb?
- Peru ranks 3rd and South-East Asia (WHO region) ranks 5th of 54 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Confirmed cases of MDR-TB started treatment for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.